Assessment of Cardiac Risk in Women with Autoimmune Disease

[1] Jafri K(2018)Discordance of the Framingham cardiovascular risk score and the 2013 American College of Cardiology/American Heart Association risk score in systemic lupus erythematosus and rheumatoid arthritis Clin Rheumatol 37 467-474

[2] Ogdie A(2003)The epidemiology of autoimmune diseases Autoimmun Rev 2 119-125

[3] Qasim A(2018)Atherosclerotic vascular disease in the autoimmune rheumatologic woman Clin Cardiol 41 258-263

[4] Patterson SL(2012)Inflammatory arthritis as a novel risk factor for cardiovascular disease Eur J Intern Med 23 575-579

[5] Gianfrancesco M(2014)Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions Eur Heart J 36 482-489

[6] Izadi Z(2008)Genetically elevated C-reactive protein and ischemic vascular disease N Engl J Med 359 1897-1908

[7] Cooper GSSB(2001)NF-kappaB: pivotal mediator or innocent bystander in atherogenesis? J Clin Invest 107 255-264

[8] Kurmann RD(2009)Cardiovascular disease complications in systemic lupus erythematosus Biomark Med 3 239-252

[9] Mankad R(1999)Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase J Biol Chem 274 11924-11929

[10] John H(2013)Cardiovascular disease in lupus: insights and updates Curr Opin Rheumatol 25 597-605

[1] Jafri K(2018)Discordance of the Framingham cardiovascular risk score and the 2013 American College of Cardiology/American Heart Association risk score in systemic lupus erythematosus and rheumatoid arthritis Clin Rheumatol 37 467-474

[2] Ogdie A(2003)The epidemiology of autoimmune diseases Autoimmun Rev 2 119-125

[3] Qasim A(2018)Atherosclerotic vascular disease in the autoimmune rheumatologic woman Clin Cardiol 41 258-263

[4] Patterson SL(2012)Inflammatory arthritis as a novel risk factor for cardiovascular disease Eur J Intern Med 23 575-579

[5] Gianfrancesco M(2014)Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions Eur Heart J 36 482-489

[6] Izadi Z(2008)Genetically elevated C-reactive protein and ischemic vascular disease N Engl J Med 359 1897-1908

[7] Cooper GSSB(2001)NF-kappaB: pivotal mediator or innocent bystander in atherogenesis? J Clin Invest 107 255-264

[8] Kurmann RD(2009)Cardiovascular disease complications in systemic lupus erythematosus Biomark Med 3 239-252

[9] Mankad R(1999)Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase J Biol Chem 274 11924-11929

[10] John H(2013)Cardiovascular disease in lupus: insights and updates Curr Opin Rheumatol 25 597-605